JP2012513398A5 - - Google Patents

Download PDF

Info

Publication number
JP2012513398A5
JP2012513398A5 JP2011542470A JP2011542470A JP2012513398A5 JP 2012513398 A5 JP2012513398 A5 JP 2012513398A5 JP 2011542470 A JP2011542470 A JP 2011542470A JP 2011542470 A JP2011542470 A JP 2011542470A JP 2012513398 A5 JP2012513398 A5 JP 2012513398A5
Authority
JP
Japan
Prior art keywords
phenoxy
carboxylic acid
chroman
ylcarbamoyl
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011542470A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012513398A (ja
JP5575799B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/068672 external-priority patent/WO2010075200A1/en
Publication of JP2012513398A publication Critical patent/JP2012513398A/ja
Publication of JP2012513398A5 publication Critical patent/JP2012513398A5/ja
Application granted granted Critical
Publication of JP5575799B2 publication Critical patent/JP5575799B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011542470A 2008-12-22 2009-12-18 7−フェノキシクロマンカルボン酸誘導体 Expired - Fee Related JP5575799B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13998108P 2008-12-22 2008-12-22
US61/139,981 2008-12-22
PCT/US2009/068672 WO2010075200A1 (en) 2008-12-22 2009-12-18 7-phenoxychroman carboxylic acid derivatives

Publications (3)

Publication Number Publication Date
JP2012513398A JP2012513398A (ja) 2012-06-14
JP2012513398A5 true JP2012513398A5 (enExample) 2013-01-31
JP5575799B2 JP5575799B2 (ja) 2014-08-20

Family

ID=42060604

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011542470A Expired - Fee Related JP5575799B2 (ja) 2008-12-22 2009-12-18 7−フェノキシクロマンカルボン酸誘導体

Country Status (7)

Country Link
US (1) US8785445B2 (enExample)
EP (1) EP2379535B1 (enExample)
JP (1) JP5575799B2 (enExample)
CN (1) CN102325767B (enExample)
CA (1) CA2748099C (enExample)
TW (1) TWI469977B (enExample)
WO (1) WO2010075200A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2582161T3 (es) * 2008-06-25 2016-09-09 Array Biopharma, Inc. Derivados del ácido fenoxicroman carboxílico sustituidos en 6
EP2376485B1 (en) 2008-12-19 2017-12-06 Vertex Pharmaceuticals Incorporated Pyrazine derivatives useful as inhibitors of atr kinase
JP2013526540A (ja) * 2010-05-12 2013-06-24 バーテックス ファーマシューティカルズ インコーポレイテッド Atrキナーゼ阻害剤として有用な化合物
KR20130066633A (ko) 2010-05-12 2013-06-20 버텍스 파마슈티칼스 인코포레이티드 Atr 키나제의 억제제로서 유용한 화합물
BR112014007690B1 (pt) 2011-09-30 2022-10-04 Vertex Pharmaceuticals Incorporated Usos de inibidores de atr no tratamento de câncer pancreático e câncer de pulmão de células não pequenas
CN103987709B (zh) 2011-09-30 2016-09-28 沃泰克斯药物股份有限公司 用于制备可用作atr激酶抑制剂的化合物的方法
EP3311816A1 (en) 2012-04-05 2018-04-25 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase for the treatment of cancer
CA2873097A1 (en) 2012-05-11 2013-11-14 Todd M. Hansen Pyridazine and pyridine derivatives as nampt inhibitors
TWI654180B (zh) 2012-06-29 2019-03-21 美商艾佛艾姆希公司 殺真菌之雜環羧醯胺
US8999632B2 (en) 2012-10-04 2015-04-07 Vertex Pharmaceuticals Incorporated Method for measuring ATR inhibition mediated increases in DNA damage
EP4420734A3 (en) * 2015-02-13 2024-11-06 Institut National de la Santé et de la Recherche Médicale Ptgdr-1 and/or ptgdr-2 antagonists for preventing and/or treating systemic lupus erythematosus
RU2768621C1 (ru) 2015-09-30 2022-03-24 Вертекс Фармасьютикалз Инкорпорейтед Способ лечения рака с использованием комбинации повреждающих днк средств и ингибиторов atr
WO2021063735A1 (en) 2019-10-02 2021-04-08 Basf Se New bicyclic pyridine derivatives
CN111228247B (zh) * 2019-12-05 2023-01-31 青海大学 一种用于治疗包虫病的含苯亚甲基丙酮药物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070119975A1 (en) * 2001-11-28 2007-05-31 Hunnicutt S B Method and Apparatus for Reducing the Precipitation Rate of an Irrigation Sprinkler
CA2511214C (en) * 2002-12-20 2012-12-18 Tularik, Inc. Asthma and allergic inflammation modulators
GB0611781D0 (en) 2006-06-14 2006-07-26 Argenta Discovery Ltd 2-Oxo-2H-Chromene Compounds
HRP20130004T8 (en) * 2006-08-21 2013-03-31 Array Biopharma, Inc. 4-substituted phenoxyphenylacetic acid derivatives
WO2008054675A2 (en) 2006-10-31 2008-05-08 Merck & Co., Inc. Antidiabetic bicyclic compounds
US7960567B2 (en) * 2007-05-02 2011-06-14 Amgen Inc. Compounds and methods useful for treating asthma and allergic inflammation
US8362056B2 (en) 2007-11-05 2013-01-29 Array Biopharma Inc. 4-heteroaryl-substituted phenoxyphenylacetic acid derivatives
ES2582161T3 (es) * 2008-06-25 2016-09-09 Array Biopharma, Inc. Derivados del ácido fenoxicroman carboxílico sustituidos en 6

Similar Documents

Publication Publication Date Title
JP2012513398A5 (enExample)
TWI579284B (zh) 咪唑并吡咯啶酮化合物
CA2742007C (en) Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
AU2016276806B2 (en) Tricyclic derivative compound, method for preparing same, and pharmaceutical composition comprising same
JP5797345B2 (ja) プロテインキナーゼに対する阻害活性を有するチエノ[3,2−d]ピリミジン誘導体
RU2586974C2 (ru) Ингибиторы катехол-о-метилтрансферазы и их применение при лечении психотических расстройств
JP5543980B2 (ja) 新規抗血小板薬
KR102007056B1 (ko) 과증식성 질환 치료시 Bub1 키나제 저해제로 사용하기 위한 치환된 벤질인다졸
AU2014219855B2 (en) Trk-inhibiting compound
EP2909193B1 (en) Phenyl linked quinolinyl modulators of ror-gamma-t
CN103497188B (zh) 调节c‑fms和/或c‑kit活性的化合物及其应用
JP5452490B2 (ja) キナーゼ阻害剤の組成物ならびに癌およびキナーゼに関連する他の疾患の治療のためのそれらの使用
TW202114995A (zh) 作為NAv1.8抑制劑之2,3-二氫喹唑啉化合物
JP7007290B2 (ja) デングウイルス複製阻害剤としての置換インドール化合物誘導体
JP2017526622A (ja) 3−アミノ−1,5,6,7−テトラヒドロ−4h−インドール−4−オン類
JP2009529047A5 (enExample)
TW200536851A (en) Compounds and methods of use
JP2010522765A5 (enExample)
JP2017505808A (ja) 新規グルタミナーゼ阻害剤
EP2595482A1 (en) Aldosterone synthase inhibitors
JP2013519724A5 (enExample)
JP2011509301A5 (enExample)
JP2019505595A5 (enExample)
AU2012250059A1 (en) Aldosterone synthase inhibitors
JP2006507355A5 (enExample)